<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Erwin Ho</style></author><author><style face="normal" font="default" size="100%">Julie Schenk</style></author><author><style face="normal" font="default" size="100%">Veronik Hutse</style></author><author><style face="normal" font="default" size="100%">Vanessa Suin</style></author><author><style face="normal" font="default" size="100%">Amber Litzroth</style></author><author><style face="normal" font="default" size="100%">Stéphanie Blaizot</style></author><author><style face="normal" font="default" size="100%">Sereina A Herzog</style></author><author><style face="normal" font="default" size="100%">Vera Verburgh</style></author><author><style face="normal" font="default" size="100%">Marjorie Jacques</style></author><author><style face="normal" font="default" size="100%">Rahman, Abbas</style></author><author><style face="normal" font="default" size="100%">Michielsen, Peter</style></author><author><style face="normal" font="default" size="100%">Van Damme, Pierre</style></author><author><style face="normal" font="default" size="100%">Steven Van Gucht</style></author><author><style face="normal" font="default" size="100%">Heidi Theeten</style></author><author><style face="normal" font="default" size="100%">Hens, Niel</style></author><author><style face="normal" font="default" size="100%">Thomas Vanwolleghem</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.</style></title><secondary-title><style face="normal" font="default" size="100%">J Viral Hepat</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgium</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatitis Antibodies</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatitis E</style></keyword><keyword><style  face="normal" font="default" size="100%">Hepatitis E virus</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunoglobulin G</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunoglobulin M</style></keyword><keyword><style  face="normal" font="default" size="100%">Seroepidemiologic Studies</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2020 11</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">27</style></volume><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;Recent European studies suggest an emergence of hepatitis E virus (HEV) infection. We evaluated trends in birth cohort-specific HEV seroprevalence and regional differences in Belgium. HEV IgG seroprevalence was analysed on national serum banks (1579 and 2087 samples for 2006 and 2014, respectively. Hepatitis E virus antigen was tested on positive samples. Observed data were modelled using a generalized additive model with a complementary log-log link. No significant differences between birth cohorts or sexes were found. Modelling identified the individual's age and province as relevant factors. The probability of HEV seropositivity increases significantly with age. An estimated total of 434&amp;nbsp;819 (yearly rate of 54,352) (sero-)infections were found between 2006 and 2014. Overall, HEV IgG seroprevalences were 4.1% (64/1579, 95% CI 3.1-5.1) and 5.8% (121/2087, CI 4.8-6.9) in 2006 and 2014, respectively. Observed HEV antigen seroprevalence was 0.027% (1/3666) for the entire cohort. These results show stable HEV IgG seroprevalence in Belgium.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">11</style></issue></record></records></xml>